CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Clinical trials for CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New oral drug could stop blood cancer before it starts
Disease control Not yet recruitingThis study tests a low-dose oral drug (decitabine plus tetrahydrouridine) in 80 adults aged 60-85 with a high-risk blood condition called CCUS, which often leads to blood cancer. The drug aims to reduce harmful blood cell mutations and restore normal blood cell production without…
Matched conditions: CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Disease control
Last updated May 26, 2026 10:53 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Not yet recruitingThis study creates a registry of 500 adults with myelodysplastic syndromes (MDS) or related conditions. Researchers will collect medical data and blood or bone marrow samples over time to track how these diseases progress. The goal is to better understand these rare blood disorde…
Matched conditions: CCUS CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated May 26, 2026 10:46 UTC